A Study of RO6870810/TEN-010 in Participants With Acute Myeloid Leukemia and Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy Study of CC-486 in Subjects With Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE2
Study of TCP-ATRA for Adult Patients With AML and MDS
- Status
- COMPLETED
- Phase
- PHASE1
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
- Status
- RECRUITING
- Phase
- N/A
Extension Study to Evaluate Long-Term Effects of Luspatercept in Patients With Myelodysplastic Syndromes (MDS) (A536-05/MK-6143-003)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Aezea® (Cenersen) in Transfusion Dependent Anemia Associated With Myelodysplastic Syndrome (MDS)
- Status
- TERMINATED
- Phase
- PHASE1
Phase I/II Trial to Investigate BI 836858 in Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- PHASE2
Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients With Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE2
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Volasertib in Combination With Azacitidine in Japanese Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Intra-Osseous Co-Transplant of UCB and hMSC
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Validation of a Comprehensive Health Status Assessment Scale in Elderly Patients (≥ 65 Years) With Hematological Malignancies
- Status
- COMPLETED
- Phase
- N/A
A Study of Epoetin Beta Treatment in Anemic Participants With Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE4
Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms
- Status
- COMPLETED
- Phase
- PHASE2
Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation
- Status
- RECRUITING
- Phase
- PHASE1
Azacitidine Plus Deferasirox (ICL670) in Higher Risk Myelodysplastic Syndromes (MDS)
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Galunisertib in Participants With Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3